NZ606969A - A method of treating alzheimer’s disease - Google Patents
A method of treating alzheimer’s diseaseInfo
- Publication number
- NZ606969A NZ606969A NZ606969A NZ60696911A NZ606969A NZ 606969 A NZ606969 A NZ 606969A NZ 606969 A NZ606969 A NZ 606969A NZ 60696911 A NZ60696911 A NZ 60696911A NZ 606969 A NZ606969 A NZ 606969A
- Authority
- NZ
- New Zealand
- Prior art keywords
- disease
- treating alzheimer
- homeopathic
- activated
- potentiated form
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 2
- 230000001632 homeopathic effect Effects 0.000 abstract 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 abstract 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000003511 endothelial effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010130353/15A RU2542445C2 (ru) | 2010-07-21 | 2010-07-21 | Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера |
| RU2011127058/15A RU2536232C2 (ru) | 2011-07-01 | 2011-07-01 | Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера |
| PCT/IB2011/002434 WO2012010978A2 (en) | 2010-07-21 | 2011-07-15 | A method of treating alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ606969A true NZ606969A (en) | 2015-08-28 |
Family
ID=44863153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ606969A NZ606969A (en) | 2010-07-21 | 2011-07-15 | A method of treating alzheimer’s disease |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20130058982A1 (OSRAM) |
| EP (1) | EP2596021A2 (OSRAM) |
| JP (1) | JP2013535445A (OSRAM) |
| CN (1) | CN103119060A (OSRAM) |
| AU (1) | AU2011281252A1 (OSRAM) |
| CA (1) | CA2805943A1 (OSRAM) |
| DE (1) | DE112011102409T5 (OSRAM) |
| EA (1) | EA029399B1 (OSRAM) |
| FR (1) | FR2962912A1 (OSRAM) |
| GB (1) | GB2496801B (OSRAM) |
| IT (1) | ITTO20110633A1 (OSRAM) |
| MX (1) | MX2013000808A (OSRAM) |
| NZ (1) | NZ606969A (OSRAM) |
| PH (1) | PH12013500143A1 (OSRAM) |
| UA (1) | UA107836C2 (OSRAM) |
| WO (1) | WO2012010978A2 (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| EP2593474A2 (en) | 2010-07-15 | 2013-05-22 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
| DE112011102349T5 (de) | 2010-07-15 | 2013-04-18 | Oleg Iliich Epshtein | Pharmazeutische Zusammensetzung und Behandlungsverfahren |
| CZ2013105A3 (cs) * | 2010-07-15 | 2013-05-22 | Iliich Epshtein@Oleg | Zpusob zvýsení úcinku aktivované potencované formy protilátky |
| WO2012010970A2 (en) | 2010-07-21 | 2012-01-26 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| BR112013001296A2 (pt) * | 2010-07-21 | 2017-12-19 | Lliich Epshtein Oleg | composições farmacêuticas e respectivo uso e métodos de tratamento de vertigem de diferentes origens, cinetose e distonia vascular vegetativa |
| RU2013111961A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2013111962A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| CN104324359B (zh) * | 2014-09-25 | 2016-08-17 | 中山大学 | Rry三肽在制备治疗阿尔茨海默症药物中的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| RU2156621C1 (ru) | 1999-03-04 | 2000-09-27 | Эпштейн Олег Ильич | Нейротропное лекарственное средство |
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| AU2002258518A1 (en) * | 2001-03-14 | 2002-09-24 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| US6451547B1 (en) * | 2001-04-25 | 2002-09-17 | Syn X Pharma | Process for differential diagnosis of Alzheimer's dementia and device therefor |
| UA76639C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
| UA76641C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| JP2006516089A (ja) * | 2002-10-02 | 2006-06-22 | ジェネンテック・インコーポレーテッド | 腫瘍の診断と治療のための組成物と方法 |
| TWI345470B (en) | 2003-03-14 | 2011-07-21 | Nutrition Res Inc | Homeopathic formulations useful for treating pain and/or inflammation |
| BRPI0601496B8 (pt) * | 2006-04-13 | 2021-05-25 | Miria De Amorim | composições medicamentosas, uso das mesmas, kits medicamentosos e método de aplicação das composições medicamentosas |
| BR112013001296A2 (pt) * | 2010-07-21 | 2017-12-19 | Lliich Epshtein Oleg | composições farmacêuticas e respectivo uso e métodos de tratamento de vertigem de diferentes origens, cinetose e distonia vascular vegetativa |
-
2011
- 2011-07-15 US US13/135,892 patent/US20130058982A1/en not_active Abandoned
- 2011-07-15 WO PCT/IB2011/002434 patent/WO2012010978A2/en not_active Ceased
- 2011-07-15 AU AU2011281252A patent/AU2011281252A1/en not_active Abandoned
- 2011-07-15 JP JP2013520241A patent/JP2013535445A/ja active Pending
- 2011-07-15 MX MX2013000808A patent/MX2013000808A/es not_active Application Discontinuation
- 2011-07-15 DE DE112011102409T patent/DE112011102409T5/de not_active Withdrawn
- 2011-07-15 CA CA2805943A patent/CA2805943A1/en not_active Abandoned
- 2011-07-15 EP EP11775840.9A patent/EP2596021A2/en not_active Ceased
- 2011-07-15 FR FR1156479A patent/FR2962912A1/fr not_active Withdrawn
- 2011-07-15 EA EA201300130A patent/EA029399B1/ru not_active IP Right Cessation
- 2011-07-15 IT IT000633A patent/ITTO20110633A1/it unknown
- 2011-07-15 PH PH1/2013/500143A patent/PH12013500143A1/en unknown
- 2011-07-15 GB GB1302929.3A patent/GB2496801B/en not_active Expired - Fee Related
- 2011-07-15 CN CN2011800454649A patent/CN103119060A/zh active Pending
- 2011-07-15 NZ NZ606969A patent/NZ606969A/en not_active IP Right Cessation
- 2011-07-15 UA UAA201300104A patent/UA107836C2/uk unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103119060A (zh) | 2013-05-22 |
| DE112011102409T5 (de) | 2013-07-04 |
| AU2011281252A1 (en) | 2013-03-07 |
| GB201302929D0 (en) | 2013-04-03 |
| EA029399B1 (ru) | 2018-03-30 |
| WO2012010978A3 (en) | 2012-04-26 |
| PH12013500143A1 (en) | 2019-09-02 |
| GB2496801A (en) | 2013-05-22 |
| GB2496801B (en) | 2018-04-11 |
| EA201300130A1 (ru) | 2013-12-30 |
| EP2596021A2 (en) | 2013-05-29 |
| UA107836C2 (uk) | 2015-02-25 |
| ITTO20110633A1 (it) | 2012-01-22 |
| CA2805943A1 (en) | 2012-01-26 |
| MX2013000808A (es) | 2013-10-28 |
| JP2013535445A (ja) | 2013-09-12 |
| WO2012010978A2 (en) | 2012-01-26 |
| FR2962912A1 (fr) | 2012-01-27 |
| US20130058982A1 (en) | 2013-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ606969A (en) | A method of treating alzheimer’s disease | |
| NZ606988A (en) | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia | |
| NZ606970A (en) | A method of treating attention deficit hyperactivity disorder | |
| MY159398A (en) | Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide | |
| EA201291034A1 (ru) | АПТАМЕРЫ К β-NGF И ИХ ПРИМЕНЕНИЕ ПРИ ЛЕЧЕНИИ B-NGF-ОПОСРЕДОВАННЫХ ЗАБОЛЕВАНИЙ И РАССТРОЙСТВ | |
| PH12013501636A1 (en) | Treatment of osteoarthritis and pain | |
| PH12018500641A1 (en) | Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) | |
| MD20140035A2 (ro) | Metodă de tratament al hepatitei virale C | |
| MX357965B (es) | Composicion farmaceutica para el tratamiento y/o prevencion de cancer de vesicula biliar. | |
| EA201490004A1 (ru) | Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей | |
| TN2014000206A1 (en) | Antibody molecules having specificity for human ox40 | |
| PH12015500196B1 (en) | Methods of treating a tauopathy | |
| EA201591131A1 (ru) | Днк-конструкции антитела и способ их применения | |
| UA112288C2 (uk) | Склад антитіла, що специфічно зв'язує рецептор а іl-17, і терапевтичні режими | |
| NZ705008A (en) | Novel modulators and methods of use | |
| UA111340C2 (uk) | Антитіло, яке специфічно зв'язується з tnf-альфа людини | |
| MY163257A (en) | Humanised anti-cd52 antibodies | |
| TR201905101T4 (tr) | Doku faktörü yolak inhibitörüne (TFPI) karşı monoklonal antikorlar. | |
| WO2012014078A3 (en) | Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy | |
| GB2497453A (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
| WO2013122544A3 (en) | IL-1β NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES | |
| NZ628454A (en) | Combination therapy of anti-mif antibodies and glucocorticoids | |
| MX2013009529A (es) | Tratamiento de enfermedad de crohn con fistulas. | |
| HK1190415A (en) | Humanised anti-cd52 antibodies | |
| UA36019U (ru) | Способ приготовления субстрата тканевого антигена |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 JUL 2018 BY FREEHILLS PATENT ATTORNEYS Effective date: 20160217 |
|
| LAPS | Patent lapsed |